Robert James Wills's Net Worth

$1.56 Million

Estimate Recalculated Apr 10, 2024 07:40PM EST

Who is Robert James Wills?

Robert James Wills has an estimated net worth of $1.56 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., Milestone Pharmaceuticals Inc., and Oncternal Therapeutics, Inc..

SEC CIK

Robert James Wills's CIK is 0001634189

Past Insider Trading and Trends

2017 was Robert James Wills's most active year for acquiring shares with 8 total transactions. Robert James Wills's most active month to acquire stocks was the month of May. 2019 was Robert James Wills's most active year for disposing of shares, totalling 1 transactions. Robert James Wills's most active month to dispose stocks was the month of May. 2016 saw Robert James Wills paying a total of $226,216.86 for 657,456 shares, this is the most they've acquired in one year. In 2019 Robert James Wills cashed out on 30,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CymaBay Therapeutics, Inc. (CBAY) Snapshot price: $24.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-30.00K
—
—
0
Mar 22
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Sep 22
Form 4
+20.00%
5K
$6.84
$34,220.70
30K
Aug 1
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Apr 27
Form 4
∞
25K
$2.43
$60,857.50
25K
Sep 6
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Apr 16
Form 3
—
0
—
—
0
No matching records found

Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
∞
15K
$4.93
$73,950.00
15K
Oct 19
Form 4
—
0
—
—
0
Jul 5
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Oct 1
Form 3
—
0
—
—
0
No matching records found

Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $9.6

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+44.63%
3.09K
$8.96
$27,654.57
10K
Apr 8
Form 4
∞
6.91K
$8.48
$58,602.37
6.91K
Mar 28
Form 4
-100.00%
-980.00
$9.04
-$8,859.20
0
Feb 23
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 25
Form 4/A
—
0
—
—
0
Sep 12
Form 4/A
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Sep 12
Form 4
+3.78%
5K
$16.75
$83,750.00
137.34K
Jun 26
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Feb 28
Form 4
+10.29%
123.46K
$0.81
$99,999.36
1.32M
Oct 14
Form 4
+9.09%
100K
$0.65
$65,360.00
1.2M
Jun 16
Form 4
—
0
—
—
0
Jan 1
Form 4
+85.67%
46.14K
$0.96
$44,247.20
100K
May 13 - May 14
Form 4
+7.72%
3.86K
$0.80
$3,088.00
53.86K
May 11
Form 4
∞
50K
$0.80
$40,000.00
50K
May 8
Form 4
∞
1M
—
—
1M
Mar 2
Form 3
—
0
—
—
0
No matching records found